. "4 Immunization." Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: The National Academies Press, 2010.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C
TABLE 4-4 Studies of Hepatitis B Vaccination Rates in Injection-Drug Users
Reference
Location
Sample; Design
Cross-sectional studies of vaccination rates
Seal et al., 2000
San Francisco, CA
135 under 30 years old, 96 at least 30 years old
Cross-sectional
Lum et al., 2008
San Francisco, CA
831 young IDUs
Cross-sectional
Kuo et al., 2004
Baltimore, MD
324 IDUs, NIDUs
Cross-sectional
Additional vaccination studies
Campbell et al., 2007
5 US cities
3,181
Cohort; vaccination protocol varied by city
Altice et al., 2005
New Haven, CT; mobile health van at SEP
134 HBV-negative IDUs
Observational
Des Jarlais et al., 2001
Anchorage, AK; New York City
AK cohort referred to clinic (350); New York City cohort offered on-site vaccination at SEP (36) + small cash incentives
Cohort
Hutchinson et al., 2004
Glasgow, Scotland, prison vaccination, community assessment
In 1999, offered HBV vaccination to all inmates; surveyed new injectors (within 5 years)
